Biosimilars for Rheum Disease: Failure to Launch

]]>(MedPage Today) -- The availability of biologic biosimilars has thus far had negligible impact on prescribing practices in the United States, in stark contrast to what has been observed in some European countries, researchers reported.Analysis...